C Noel Bairey Merz1, Holly Andersen2, Emily Sprague3, Adam Burns3, Mark Keida3, Mary Norine Walsh4, Phyllis Greenberger5, Susan Campbell6, Irene Pollin7, Cassandra McCullough8, Nancy Brown9, Marjorie Jenkins10, Rita Redberg11, Paula Johnson12, British Robinson13. 1. Barbra Streisand Women's Heart Center, Cedars-Sinai Heart Institute, Los Angeles, California. Electronic address: merz@cshs.org. 2. Ronald O. Perelman Heart Institute, New York Presbyterian Hospital, New York, New York. 3. GMMB-GfK (Greer, Margolis, Mitchell, Burns-Gesellschaft für Konsumforschung), Washington, DC. 4. St. Vincent Hospital, Indianapolis, Indiana. 5. Society of Women's Health Research, Washington, DC. 6. WomenHeart, Washington, DC. 7. Linda Joy Pollin Women's Heart Health Program, Los Angeles, California. 8. Association of Black Cardiologists, Washington, DC. 9. American Heart Association, Dallas, Texas. 10. Food and Drug Administration Office of Women's Health, Bethesda, Maryland. 11. University of California, San Francisco, California. 12. Wellesley College, Wellesley, Massachusetts. 13. Women's Heart Alliance, Washington, DC.
Abstract
BACKGROUND: Cardiovascular disease (CVD) is the number 1 killer of women in the United States, yet few younger women are aware of this fact. CVD campaigns focus little attention on physicians and their roles in assessing risk. OBJECTIVES: In 2014, the Women's Heart Alliance (WHA) conducted a nationwide survey to determine barriers and opportunities for women and physicians with regard to CVD. METHODS: From September 18 to 26, 2014, a total of 1,011 U.S. women (age 25 to 60 years) were interviewed using the GfK ("Gesellschaft für Konsumforschung" Knowledge Panel). From May 6 to 12, 2014, the e-Rewards Inc. Physician and Healthcare Professional Panel surveyed 200 primary care physicians (PCPs) and 100 cardiologists. RESULTS: Overall, 45% of women were unaware that CVD is the number 1 killer of women; only 11% knew a woman who died from CVD. Overall, 45% of women reported it was common to cancel or postpone a physician appointment until losing weight. CVD was rated as the top concern by only 39% of PCPs, after weight and breast health. Only 22% of PCPs and 42% of cardiologists (p = 0.0477) felt extremely well prepared to assess CVD risk in women, while 42% and 40% felt well-prepared (p = NS), respectively. Few comprehensively implemented guidelines. CONCLUSIONS: CVD was rated as the top concern less frequently than weight issues by both women and physicians. Social stigma particularly regarding body weight appeared to be a barrier. Physicians reported limited training and use of guideline assessment, whereas most supported a campaign and improved physician education. Campaigns should make CVD "real" to U.S. women, countering stereotypes with facts and validated assessments. Both community women and physicians endorsed investment in women's CVD research and physician education.
BACKGROUND:Cardiovascular disease (CVD) is the number 1 killer of women in the United States, yet few younger women are aware of this fact. CVD campaigns focus little attention on physicians and their roles in assessing risk. OBJECTIVES: In 2014, the Women's Heart Alliance (WHA) conducted a nationwide survey to determine barriers and opportunities for women and physicians with regard to CVD. METHODS: From September 18 to 26, 2014, a total of 1,011 U.S. women (age 25 to 60 years) were interviewed using the GfK ("Gesellschaft für Konsumforschung" Knowledge Panel). From May 6 to 12, 2014, the e-Rewards Inc. Physician and Healthcare Professional Panel surveyed 200 primary care physicians (PCPs) and 100 cardiologists. RESULTS: Overall, 45% of women were unaware that CVD is the number 1 killer of women; only 11% knew a woman who died from CVD. Overall, 45% of women reported it was common to cancel or postpone a physician appointment until losing weight. CVD was rated as the top concern by only 39% of PCPs, after weight and breast health. Only 22% of PCPs and 42% of cardiologists (p = 0.0477) felt extremely well prepared to assess CVD risk in women, while 42% and 40% felt well-prepared (p = NS), respectively. Few comprehensively implemented guidelines. CONCLUSIONS: CVD was rated as the top concern less frequently than weight issues by both women and physicians. Social stigma particularly regarding body weight appeared to be a barrier. Physicians reported limited training and use of guideline assessment, whereas most supported a campaign and improved physician education. Campaigns should make CVD "real" to U.S. women, countering stereotypes with facts and validated assessments. Both community women and physicians endorsed investment in women's CVD research and physician education.
Authors: Holly C Gooding; Courtney A Brown; Anna C Revette; Viola Vaccarino; Jingyi Liu; Sierra Patterson; Catherine Stamoulis; Sarah D de Ferranti Journal: J Adolesc Health Date: 2020-07-02 Impact factor: 5.012
Authors: Anna C O'Kelly; Erin D Michos; Chrisandra L Shufelt; Jane V Vermunt; Margo B Minissian; Odayme Quesada; Graeme N Smith; Janet W Rich-Edwards; Vesna D Garovic; Samar R El Khoudary; Michael C Honigberg Journal: Circ Res Date: 2022-02-17 Impact factor: 17.367
Authors: Simon Timpka; Jennifer J Stuart; Lauren J Tanz; Frank B Hu; Paul W Franks; Janet W Rich-Edwards Journal: Diabetes Care Date: 2018-11-19 Impact factor: 19.112
Authors: Krishna K Patel; Suzanne V Arnold; Paul S Chan; Yuanyuan Tang; Philip G Jones; Jianping Guo; Donna M Buchanan; Mohammed Qintar; Carole Decker; David A Morrow; John A Spertus Journal: Am Heart J Date: 2018-04-21 Impact factor: 4.749